Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
1996-7-31
pubmed:abstractText
True histiocytic lymphomas (THLs) are rare tumors in which the malignant cells show morphologic and immunophenotypic evidence of histiocytic differentiation. We describe THLs that arose after therapy for one case of T-lineage lymphoblastic lymphoma (LyL) and two cases of acute lymphoblastic leukemia (ALL) (both CD10+, one pre-B phenotype). The lymphoblastic neoplasms were not unusual in any way, and responded well to standard therapy. The THLs arose 10 to 20 months after complete remission was achieved for the lymphoblastic neoplasms, at which time there was still no clinical or pathologic evidence of the lymphoblastic neoplasms. All three THLs exhibited clinical and morphologic features of malignancy. Neoplastic cells in the THLs had abundant eosinophilic vacuolated cytoplasm and pleomorphic nuclei, and expressed histiocytic antigens in the absence of lymphocyte-specific lineage markers. Because THLs are rare neoplasms, their occurrence after otherwise successful therapy for lymphoblastic neoplasms in these three cases may constitute a distinct clinicopathologic entity.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/6-Mercaptopurine, http://linkedlifedata.com/resource/pubmed/chemical/Asparaginase, http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/Cyclophosphamide, http://linkedlifedata.com/resource/pubmed/chemical/Cytarabine, http://linkedlifedata.com/resource/pubmed/chemical/Daunorubicin, http://linkedlifedata.com/resource/pubmed/chemical/Etoposide, http://linkedlifedata.com/resource/pubmed/chemical/Ifosfamide, http://linkedlifedata.com/resource/pubmed/chemical/Methotrexate, http://linkedlifedata.com/resource/pubmed/chemical/Methylprednisolone, http://linkedlifedata.com/resource/pubmed/chemical/Prednisolone, http://linkedlifedata.com/resource/pubmed/chemical/Prednisone, http://linkedlifedata.com/resource/pubmed/chemical/Vincristine
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0006-4971
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
87
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5207-12
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:8652834-6-Mercaptopurine, pubmed-meshheading:8652834-Adult, pubmed-meshheading:8652834-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:8652834-Asparaginase, pubmed-meshheading:8652834-Bone Neoplasms, pubmed-meshheading:8652834-Child, pubmed-meshheading:8652834-Cisplatin, pubmed-meshheading:8652834-Combined Modality Therapy, pubmed-meshheading:8652834-Cyclophosphamide, pubmed-meshheading:8652834-Cytarabine, pubmed-meshheading:8652834-Daunorubicin, pubmed-meshheading:8652834-Etoposide, pubmed-meshheading:8652834-Fatal Outcome, pubmed-meshheading:8652834-Humans, pubmed-meshheading:8652834-Ifosfamide, pubmed-meshheading:8652834-Lymphoma, Large B-Cell, Diffuse, pubmed-meshheading:8652834-Male, pubmed-meshheading:8652834-Mediastinal Neoplasms, pubmed-meshheading:8652834-Methotrexate, pubmed-meshheading:8652834-Methylprednisolone, pubmed-meshheading:8652834-Neoplasms, Second Primary, pubmed-meshheading:8652834-Neoplastic Stem Cells, pubmed-meshheading:8652834-Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, pubmed-meshheading:8652834-Precursor Cell Lymphoblastic Leukemia-Lymphoma, pubmed-meshheading:8652834-Prednisolone, pubmed-meshheading:8652834-Prednisone, pubmed-meshheading:8652834-Remission Induction, pubmed-meshheading:8652834-Scapula, pubmed-meshheading:8652834-Spinal Neoplasms, pubmed-meshheading:8652834-Vincristine
pubmed:year
1996
pubmed:articleTitle
True histiocytic lymphoma following therapy for lymphoblastic neoplasms.
pubmed:affiliation
Department of Pathology, Stanford University Medical Center, Stanford, CA., USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Case Reports, Research Support, Non-U.S. Gov't